(Q37738728)

22 August 2017

1 reference

title

Best strategies for hypertension management in type 2 diabetes and obesity (English)

1 reference

22 August 2017

main subject

arterial hypertension

0 references

0 references

0 references

Darren M Allcock

1

1 reference

22 August 2017

James R Sowers

series ordinal

2

1 reference

22 August 2017

publication date

1 April 2010

1 reference

22 August 2017

published in

Current diabetes report

1 reference

22 August 2017

volume

10

1 reference

22 August 2017

issue

2

1 reference

22 August 2017

page(s)

139-144

1 reference

Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension

22 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-010-0100-Z

Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus

21 January 2018

1 reference

12 December 2020

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

12 December 2020

Low-dose spironolactone in the management of resistant hypertension: a surveillance study

1 reference

12 December 2020

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group

1 reference

12 December 2020

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

1 reference

12 December 2020

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

1 reference

12 December 2020

A comparison of atenolol and nebivolol in isolated systolic hypertension

1 reference

12 December 2020

Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial.

1 reference

12 December 2020

Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide

1 reference

12 December 2020

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

12 December 2020

Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril

1 reference

12 December 2020

Ramipril and the development of diabetes.

1 reference

12 December 2020

Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure

1 reference

12 December 2020

Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study

1 reference

12 December 2020

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

12 December 2020

ASH position paper: treatment of hypertension in patients with diabetes-an update.

1 reference

12 December 2020

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group

1 reference

12 December 2020

Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism

1 reference

12 December 2020

Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.

1 reference

12 December 2020

Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

1 reference

12 December 2020

Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy

1 reference

12 December 2020

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy

1 reference

12 December 2020

Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension-2. STOP Hypertension-2 Study Group.

1 reference

12 December 2020

Possible involvement of Akt activity in endothelial dysfunction in type 2 diabetic mice

1 reference

12 December 2020

10.1007/S11892-010-0100-Z

Identifiers

DOI

1 reference

22 August 2017

1 reference